6 Recruiting Glioblastoma (GBM) Phase 1 Clinical Trials
Active phase 1 studies for glioblastoma (gbm) enrolling across the USA. Verify eligibility and contact site coordinators.
All Glioblastoma (GBM) studiesPhase 1 Studies for Glioblastoma (GBM)
🟡 Not Yet Recruiting Phase1 / Phase2
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy
📍 Miami Herbert Wertheim Cancer Institute — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Early Phase1
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
📍 Ohio State University Hospital — Columbus, Ohio
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
📍 Mayo Clinic Hospital — Phoenix, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1
Study of Low-Intensity Focused Ultrasound in Combination With Immunotherapy in Newly Diagnosed Unmethylated Glioblastoma
📍 University of Virginia — Charlottesville, Virginia
View Study & Checklist ➔ 🟢 Recruiting Early Phase1
BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
View Study & Checklist ➔